BioSpace News Archive

MicroPort CRM, a subsidiary of MicroPort Scientific Corporation, a pioneering company in the field of Cardiac Rhythm Management, has launched an online education website, MicroPort Academy CRM.

The growing prevalence of coronary artery diseases stands as a key factor aiding in expansion of the global antisense and RNAi therapeutics market and is likely to continue so during the forecast period set between 2020 and 2030.

Industrial microbiology encompasses the use of microorganisms and their metabolites for a wide variety of industrial products.

During the course of the 4th quarter, challenges associated with the COVID-19 global pandemic increased and impacted the company’s commercial activity.

IQVIA Holdings Inc. announced that its wholly owned subsidiary, IQVIA Inc., intends to raise €1,450,000,000 in gross proceeds through an offering of senior notes due 2026 and senior notes due 2029.

Announces unaudited 2020 full-year revenue of at least $45 million, representing growth of at least 63%, each above prior forecast

Liam Kelly, Chairman, President and CEO, Teleflex Incorporated, is scheduled to speak at the Raymond James 42nd Annual Institutional Investors Conference on Tuesday, March 2, 2021 at 12:30 p.m..

Epizyme, a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, announced that management will host a conference call and webcast to discuss its fourth quarter and full year 2020 financial results and other business highlights and will participate in two upcoming investor conferences.

ERS Genomics Limited and ZeClinics announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

InteRNA Technologies announced that the first patient has been dosed in the first cohort of its first-in-human Phase I study with the Company’s lead microRNA candidate, INT-1B3.